RSEGX
Price
$57.56
Change
-$0.53 (-0.91%)
Updated
Oct 7 closing price
Net Assets
399.67M
VSGIX
Price
$84.85
Change
-$0.95 (-1.11%)
Updated
Oct 7 closing price
Net Assets
39.1B
Interact to see
Advertisement

RSEGX vs VSGIX

Header iconRSEGX vs VSGIX Comparison
Open Charts RSEGX vs VSGIXBanner chart's image
Victory RS Small Cap Growth A
Price$57.56
Change-$0.53 (-0.91%)
VolumeN/A
Net Assets399.67M
Vanguard Small Cap Growth Index I
Price$84.85
Change-$0.95 (-1.11%)
VolumeN/A
Net Assets39.1B
RSEGX vs VSGIX Comparison Chart in %
View a ticker or compare two or three
VS
RSEGX vs. VSGIX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSEGX is a Hold and VSGIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSGIX has more cash in the bank: 39.1B vs. RSEGX (400M). VSGIX pays higher dividends than RSEGX: VSGIX (0.56) vs RSEGX (0.00). RSEGX was incepted earlier than VSGIX: RSEGX (38 years) vs VSGIX (25 years). RSEGX (1.41) is less costly to investors than VSGIX (0.06). RSEGX is a more actively managed with annual turnover of: 120.00 vs. VSGIX (21.00). RSEGX has a lower initial minimum investment than VSGIX: RSEGX (2500) vs VSGIX (5000000). VSGIX annual gain was more profitable for investors over the last year : 15.06 vs. RSEGX (1.63). VSGIX return over 5 years is better than : 34.52 vs. RSEGX (-36.82).
RSEGXVSGIXRSEGX / VSGIX
Total Expense Ratio1.400.062,333%
Annual Report Gross Expense Ratio1.410.062,350%
Fund Existence38 years25 years-
Gain YTD-0.2928.948-3%
Front Load6%N/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets400M39.1B1%
Annual Yield % from dividends0.000.56-
Returns for 1 year1.6315.0611%
Returns for 3 years23.2853.7143%
Returns for 5 years-36.8234.52-107%
Returns for 10 years-12.55150.41-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEIX34.86N/A
N/A
Principal Glb Emerging Markets Inst
ETIHX42.42N/A
N/A
Eventide Healthcare & Life Sciences I
ENHNX10.33N/A
N/A
Cullen Enhanced Equity Income I
LICOX18.69N/A
N/A
Lord Abbett International Equity F3
RGABX78.57-0.51
-0.64%
American Funds Growth Fund of Amer R2